Arun Kunwar

Arun Kunwar
Kanti Children´s Hospital

M.D Psychiatry/ M.D. Child and Adolescent Psychiat

About

27
Publications
11,453
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
435
Citations
Introduction
Additional affiliations
September 2005 - present
State University of New York Upstate Medical University
Position
  • Research Assistant

Publications

Publications (27)
Article
Full-text available
Nepal is a low and medium-income country (LMIC), situated in South-east Asia, with a population of 29 million, of which, 40–50% are children and adolescents. The Coronavirus Disease 2019 (COVID-19) pandemic has affected the lives of people around the world, including Nepal. The child and adolescent mental health (CAMH) needs and services in Nepal h...
Article
Full-text available
Parenting is both an art and science of nurturing a child that comes very naturally to some. In today’s world, the fundamentals of parenting are getting challenged but it has been even more magnified during the coronavirus 2019 (COVID-19) pandemic. The mental health of children is bound to be affected by the stress related to COVID-19 owing to loss...
Article
Full-text available
Childhood psychosis is an extremely rare condition. We describe the case of 6.5 yr old male child who presented with symptoms suggestive of psychosis and later responded well to antipsychotic clozapine. This case study reveals that the identification of very early onset psychosis is challenging and treatment is crucial for prevention of long-term d...
Article
Full-text available
The present article probes the current situation of doctors and health workers in Nepal as the impact of COVID-19 pandemic. It mainly discusses the social, occupational and psychological effects on the professionals. The article also documents the global occurrences and data related to COVID-19 pandemic. Lastly, it enlists the key recommendations t...
Article
Full-text available
CAMH in Nepal is an article about the current scenario in Child and Adolescent Psychiatry in Nepal including research, training, CAP services and finally the way forward for CAP. Can be read from page 30 in the journal attached below
Article
Full-text available
Introduction: Globally, 10-20% of children and adolescents suffer from mental disorders, with half of all them starting by the age of 14 and three-quarters before the age of 25. In Nepal, 40% of the population is younger than 18 years of age, and as such there is a large proportion of the population that is at risk of developing a mental disorder....
Article
DOI: http://dx.doi.org/10.3126/jpan.v1i1.9923 Journal of Psychiatrists' Association of Nepal Vol.1(1) 2011: 20-23
Article
DOI: http://dx.doi.org/10.3126/jpan.v1i1.9920 Journal of Psychiatrists' Association of Nepal Vol.1(1) 2011: 11-12
Article
Full-text available
Velo-cardio-facial syndrome (VCFS) has been identified as an important risk factor for psychoses, with up to 32% of individuals with VCFS developing a psychotic illness. Individuals with VCFS thus form a unique group to identify and explore early symptoms and biological correlates of psychosis. In this study, we examined if cortical gyrification pa...
Article
A rich set of reflections on experiences with the Inter-Agency Standing Committee Mental Health and Psychosocial Support Guidelines in Emergency Settings has recently been published in this journal. This paper describes a case study of using the guidelines in Nepal, which focused primarily on detailed implementation of preparatory steps. In effect,...
Article
Inattention and hyperactivity/ impulsivity are the defining features of attention-deficit/hyperactivity disorder (ADHD) in both children and adults; however, several core symptoms (eg, hyperactivity) mollify over time in adults. This has led to some diagnostic confusion and possibly underdiagnosis. Significant functional impairment in educational,...
Article
Full-text available
Diagnosing attention deficit hyperactivity disorder (ADHD) in adults is difficult when diagnosticians cannot establish onset prior to the DSM-IV criterion of age 7 or if the number of symptoms does not achieve the DSM threshold for diagnosis. Previous work has assessed the validity of such diagnoses based on psychiatric co-morbidity, family history...
Article
Attention-deficit/hyperactivity disorder (ADHD) often occurs along with other psychiatric disorders, with estimated comorbidity rates of 50--90%. Comorbidity greatly influences presentation, diagnosis and prognosis, complicates treatment and significantly increases the morbidity and disease burden of ADHD. Commonly co-occurring psychiatric disorder...
Article
There is a paucity of empirical support for polypharmacy with second generation (atypical) antipsychotics (SGAs), especially in understudied populations. To investigate the frequency, effectiveness, and safety of this practice in patients with severe and persistent mental illness who are chronically hospitalized. A chart review was conducted at a s...
Article
Full-text available
Personal attire is an important part of being a professional. This survey is an attempt to determine the patient's and psychiatrists view point about how a psychiatrist should dress to work. A human subjects research board approved survey of seven questions was offered to patients and a similar survey of nine questions was offered to psychiatrists....
Article
The authors endeavored to determine if there is significant weight gain during acute psychiatric inpatient hospitalization for adults and, if so, what are the contributing factors. A retrospective chart review was conducted of all patients admitted to the psychiatric inpatient unit of a University Hospital in the year 2001. The study was approved b...
Article
Though not considered a first-line treatment, oxcarbazepine has become an option in the expanding effort to ameliorate severely dysregulated mood and behavioral symptoms in youth. Like most pharmaceuticals in child and adolescent psychiatry, oxcarbazepine is not U.S. Food and Drug Administration (FDA)-approved for the treatment of psychiatric disor...
Article
The prevalence and treatment of behavioral and mental illnesses in the adolescent population are increasing, and many of the medications used are continued into adulthood. Increased vigilance is necessary when caring for this population to prevent side effects and drug interactions. In this short communication, we present a case of myocardial infar...
Article
Full-text available
To report a case of risperidone-induced hyperprolactinemia that was successfully managed with quetiapine. A 30-year-old white woman with schizoaffective disorder, depressive type, and comorbid alcohol and cocaine abuse was treated successfully for her psychotic symptoms with risperidone until she developed adverse effects consistent with hyperprola...
Article
OBJECTIVE To report a case of risperidone-induced hyperprolactinemia that was successfully managed with quetiapine. CASE SUMMARY A 30-year-old white woman with schizoaffective disorder, depressive type, and comorbid alcohol and cocaine abuse was treated successfully for her psychotic symptoms with risperidone until she developed adverse effects co...
Article
Full-text available
Depressive symptoms are wide spread in alcohol abusing patients of all ages and are much more common than diagnosable depressive disorder. Studies have reported that depression diagnosed in the current episode of alcoholism remits after two weeks of abstinence and detoxification from alcohol. Despite the high prevalence of depression in alcohol dep...

Network

Cited By